American Society of Clinical Oncology (ASCO) and Egyptian Cancer Society (ECS) leaders signed a Memorandum of Understanding (MOU) on June 2, 2025, during ASCO’s 61st Annual Meeting. The MOU formally ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

American Society of Clinical Oncology Choosing Wisely; Last Reviewed 2021 ASCO's 2021 Top Five List in Oncology The American Society of Clinical Oncology (ASCO) is a medical professional oncology ...

All International Development and Education Award (IDEA) applications are carefully reviewed and evaluated by the IDEA Steering Group. The Steering Group scores and ranks the applications using ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants ...

If you are looking for non-scientific summaries for patients, please visit the Patient Information page. TAPUR Study Analysis Plan The TAPUR Study is a phase II, non-randomized, open-label clinical ...

Key Dates Save the Date! The next ASCO Breakthrough will take place June 25-27, 2026, in Singapore and online. Attend the Meeting in Person ASCO's Media Headquarters is where you can apply for media ...

Panel Question and Answer - ASCO ...

Women Who Conquer Cancer Mentorship Awards Launched in 2016, this award program honors extraordinary women leaders in oncology and role models who have excelled as mentors and have demonstrated ...

Today, the Association for Clinical Oncology (ASCO) announced that nine outpatient oncology group practices have achieved certification through the new ASCO Patient-Centered Cancer Care Certification ...

ASCO Perspective Quote "This trial raises an intriguing hypothesis: that the increasingly popular GLP-1 medications used to treat diabetes and obesity might offer some benefit in reducing the risk of ...